Table IV.
Local reaction | Children | Adolescents | Adults |
---|---|---|---|
2–11 years | 12–15 years | 16–64 years | |
N = 18 | N = 5 | N = 28 | |
Ni = 678 | Ni = 199 | Ni = 954 | |
Total, no. of AEs (rate per infusion) | |||
27 (0.040) | 7 (0.035) | 76 (0.080) | |
Mild local reactions, no. of AEs (rate per infusion) | |||
Total | 26 (0.038) | 3 (0.015) | 67 (0.070) |
Moderate local reactions, no. of AEs (rate per infusion) | |||
Total | 1 (0.001) | 3 (0.015) | 9 (0.009) |
Infusion site nodule | 1 (0.001) | 0 | 0 |
Infusion site pruritus | 0 | 2 (0.010) | 0 |
Infusion site swelling | 0 | 1 (0.005) | 1 (0.001) |
Infusion site inflammation | 0 | 0 | 1 (0.001) |
Infusion site pain | 0 | 0 | 2 (0.002) |
Infusion site reaction | 0 | 0 | 3 (0.003) |
Infusion-related reaction | 0 | 0 | 2 (0.002) |
Severe local reactions, no. of AEs (rate per infusion) | |||
Total | 0 | 1 (0.005) | 0 |
Infusion site pruritus | 0 | 1 (0.005) | 0 |
AT all treated, N number of patients in age group, Ni number of infusions, AEs adverse events